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Male pattern baldness (MPB) is a sex-limited, age-related, complex trait. We study MPB
genetics in 205,327 European males from the UK Biobank. Here we show that MPB is
strongly heritable and polygenic, with pedigree-heritability of 0.62 (SE= 0.03) estimated
from close relatives, and SNP-heritability of 0.39 (SE= 0.01) from conventionally-unrelated
males. We detect 624 near-independent genome-wide loci, contributing SNP-heritability of
0.25 (SE= 0.01), of which 26 X-chromosome loci explain 11.6%. Autosomal genetic variance
is enriched for common variants and regions of lower linkage disequilibrium. We identify
plausible genetic correlations between MPB and multiple sex-limited markers of earlier
puberty, increased bone mineral density (rg= 0.15) and pancreatic β-cell function (rg= 0.12).
Correlations with reproductive traits imply an effect on ﬁtness, consistent with an estimated
linear selection gradient of -0.018 per MPB standard deviation. Overall, we provide genetic
insights into MPB: a phenotype of interest in its own right, with value as a model sex-limited,
complex trait.
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Male pattern baldness (MPB), or androgenetic alopecia, isan age-related condition characterised by hair thinning,miniaturisation and loss1 that affects around 80% of
European men2. The balding process is highly patterned, sug-
gesting that MPB progression is induced by some ageing-
associated program: from initial frontotemporal hairline reces-
sion to a more severe occipital horseshoe stage1. MPB has epi-
demiological links with conditions including prostate cancer3–5,
cardiometabolic disease6 and Parkinson’s Disease3. However,
despite the prevalence of MPB, the underlying biology is not well
understood.
Current evidence suggests that the genetic contribution to MPB
is strong and polygenic. Early twin studies estimated the narrow-
sense heritability (h2) on a scale of liability to be 0.817 (95%CI:
0.77–0.85). Estimates of variance explained by genome-wide
autosomal SNPs (h2SNP) range from 0.34 to 0.674,8. (See Box1 for
an overview of heritability deﬁnitions.) The Xq12 locus within the
androgen receptor gene (AR) was the ﬁrst locus to be linked to
MPB9, and was replicated across different populations10, in
linkage analysis11 and in genome-wide association studies
(GWAS)4,8,12–14. The androgen receptor binds testosterone, and
increased sensitivity is associated with more severe MPB15. Three
large-scale MPB GWAS studies were published in 2017, sig-
niﬁcantly increasing the number of candidate loci. Heilmann-
Heimbach et al.4 performed a GWAS case-control meta-analysis
on over 22,000 males, ﬁnding 63 independent MPB-associated
loci, with six on the X-chromosome. Three X-chromosome loci
had plausible candidate genes, including AR (on Xq12), TSR2 and
KLF8 (both on Xp11.21). Hagenaars et al.8 used an even larger
dataset from the UK Biobank (UKB) pilot phase (UKBv1) of over
52,000 males; they treated MPB as a ordered categorical trait with
four levels, and identiﬁed 287 independent MPB-associated var-
iants: 247 autosomal, and 40 on the X-chromosome8. In a case-
control study using the UKBv1 dataset for discovery (n= 43,590),
Pirastu et al. identiﬁed and replicated 107 independent
SNPs representing 71 MPB-associated loci (two on the X-
chromosome); 30 loci were reported to be novel16. All three
studies use different deﬁnitions for distinct loci, so the reported
numbers are difﬁcult to compare.
It is not uncommon for published GWAS to neglect analyses of
the X-chromosome, as differential dosage between the sexes
presents unique challenges17. As MPB is a sex-limited trait, it is
notable that the AR X-chromosome locus has a particularly large
effect size13, and other MPB-associated loci also converge on
androgenetic pathways15,16,18 (in addition to Wnt signalling and
apoptosis16). Since the X-chromosome contains 5% of all human
genes17, and many complex diseases (including autoimmune,
cardiovascular and psychiatric disorders) are sexually dimorphic
with respect to their lifetime risk, age of onset and symptoms19, it
is important to investigate how the X-chromosome contributes to
complex traits. Thus, MPB is an interesting trait to study due to
the known X-chromosome effect, its sex-limited expression, its
complex, polygenic basis, and its manifestation late in life.
Here, we investigate the genetic basis of MPB, drawing upon
data from 205,327 adult males of European ancestry from the
UKB. We quantify and dissect genetic variation on the autosomes
and the X-chromosome, ﬁnding h2 as high as 0.62. Our GWAS
shows that MPB is highly polygenic, and we also ﬁnd associations
with other sex-limited traits (including female-limited traits) and
bone mineral density that suggest pleiotropy.
Results
MPB sample characteristics in the UK Biobank. In the UKB, the
self-reported MPB trait was scored along a scale of 1 to 4,
representing increasing severity (Fig. 1a, Supplementary Fig. 1).
Subjects were aged between 40 and 73, with the distribution
skewed towards older ages (Fig. 1b). As expected, individuals with
lower MPB scores tended to be younger than those with higher
scores (Fig. 1b). The proportions of individuals in each MPB
category were 32%, 23%, 27% and 18% for MPB scores 1–4,
respectively (Fig. 1c). The regression coefﬁcient of raw MPB
scores on age was 0.02 (P < 2e-16); that is on average, each year
confers a 0.02 increase in MPB score. Including age-squared in
the regression did not explain signiﬁcantly more variance. The
estimate of repeatability from longitudinal self-report data from
9603 men was 0.88 (95%CI: 0.87–0.88) (Fig. 2).
Modelling of the MPB trait. For all analyses, we took as our trait
residuals from regressing the MPB scores on age, assessment
centre, ethnicity and 40 principal components calculated using
the UKB European sample. The residuals are hereafter referred
to as ‘adjusted MPB scores’ (Fig. 1d), with standard deviation
of 1.1.
Heritability estimation. First, we estimated pedigree-based h2
(h2ped) using ﬁrst-degree relatives determined by UKB kinship
coefﬁcients, including 4428 full-brothers and 789 father–son
pairs. Our estimate was 0.589 (SE= 0.026) for all ﬁrst-degree
relatives, and 0.619 (SE= 0.028) from only brother–brother
pairs. In contrast, the estimate from 789 father–son pairs (0.411,
SE= 0.071) (Fig. 2a, Supplementary Data 1) was signiﬁcantly
Box 1: Deﬁnitions of heritability
Heritability is a measure of the proportion of phenotypic variance attributed to genetic factors; here, we consider only additive genetic factors (narrow-
sense heritability, h2).
h2 is estimated from family data (h2ped) using information from close relatives (e.g. third-degree and closer). However, these estimates may be inﬂated
as relatives may share environmental exposures and non-additive genetic effects. Genetic variance can be measured directly from DNA markers such
as SNPs: so-called SNP-based heritability (h2SNP). The expected magnitude of h2SNP depends on the SNP set used in its estimation. h2SNP is estimated
based on the small genetic relationships between conventionally unrelated individuals (the estimate of h2SNP is therefore unlikely to be biased by shared
environmental exposures or non-additive genetic effects). In this method, relatedness coefﬁcients are calculated based on similarities of alleles between
pairs of individuals. Here, we used the GREML method implemented in the GCTA software20, 21. Large sample size is required to obtain an estimate of
h2SNP with a relatively small standard error because of the small variation in the genetic relatedness between unrelated individuals. The estimate of
h2SNP tends to be lower than h2ped because the former is less likely to include variation due to shared environmental effects and rare variants. The
estimates of h2SNP usually rely on similarity of common SNPs, which underestimates h2 if the genetic architecture is dominated by rare variants.
The estimates of h2SNP may be divided into further components70. Here, we separated the autosomal and X-chromosome genetic components. We also
further compartmentalised the autosomal contribution into (a) low versus high LD and (b) rare versus common SNPs in our GCTA GREML-LDMS
analysis23.
It is also possible to simultaneously estimate h2SNP and h2ped using data from both close and distant relatives, in the so-called ‘big K small K’ analysis22.
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lower (P= 0.006, two-sided test for the difference between these
estimates).
Next, we estimated SNP-based h2 (h2SNP) using pairs of
unrelated individuals and GCTA software20,21. Due to computa-
tional constraints, we deﬁned a sample of 87,957 individuals,
which included the maximum number of related pairs (genomic
relationship matrix (GRM) coefﬁcient of relationship, rel > 0.05).
From this sample, there was a maximum subset of 75,654
unrelated individuals (rel < 0.05) (Fig. 2a, Supplementary Fig. 2).
We jointly ﬁtted an autosomal and X-chromosome GRM on
these individuals, and estimated total h2SNP of 0.393 (SE= 0.006),
partitioned as 0.359 (SE= 0.006) from the autosomes and 0.034
(SE= 0.002) from the X-chromosome (Fig. 2a, Supplementary
Data 1). We conﬁrmed that these partitions made independent
contributions by calculating variances from these GRMs
separately (Supplementary Data 1).
We performed a big K small K analysis22 (n= 87,957) based on
autosomal data to estimate h2ped and h2SNP simultaneously. This
gave h2ped of 0.610 (SE= 0.030); of this, 0.349 (SE= 0.005) was
explained by common autosomal SNPs (MAF > 0.01) among
unrelated individuals (i.e. h2SNP) and 0.261 (SE= 0.030) was
explained by close relatives (big K GRM threshold replacing rel <
0.05 with 0) (Supplementary Data 1). Assuming that this estimate
reﬂects only genetic effects, this indicates that common autosomal
SNPs capture 57% of the additive genetic variance. Subsequently,
we added a third GRM built using common X-chromosome SNPs
(MAF > 0.01). Similarly, total h2ped was 0.604 (SE= 0.029),
partitioned as 0.359 from common autosomal SNPs (i.e. h2SNP,
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Fig. 1 Summary of the European, genotyped, genetically-male study population (n= 205,327). a Diagram of hair patterns and corresponding MPB scores,
adapted from the UKB baldness survey, accessible at https://biobank.ctsu.ox.ac.uk/crystal/refer.cgi?id=100423. b Density plots showing the relative age
distributions within each MPB score group. c Distribution of raw MPB scores and d adjusted MPB scores (age, assessment centre, ethnicity and 40
principal components calculated using the UKB European population)
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SE= 0.005), 0.211 (SE= 0.030) from the pedigree not captured
by common SNPs and 0.033 (SE= 0.002) from the X-
chromosome (Fig. 2a, Supplementary Data 1).
Using only unrelated individuals (n= 75,654) and the auto-
somes, we then added rare SNPs (1e-3 <MAF ≤ 0.01) and
stratiﬁed the variants across MAF and LD bins using GCTA
GREML-LDMS23. The analysis accounts for uneven distribution
of variance explained by SNPs with different MAF and LD
scores23. The total h2SNP,LDMS estimate was 0.415 (SE= 0.028,
25,246,483 autosomal SNPs, Supplementary Data 1). Genetic
variation for MPB was enriched among common (0.01 <MAF ≤
0.5) variants (h2SNP,LDMS,common= 0.434, SE= 0.008, fold-
enrichment= 3.63, P= 3.6e-177, see equation (4) for Z-score
calculation) and in lower LD regions (h2SNP,LDMS,lowLD= 0.283,
SE= 0.027, fold-enrichment= 1.36, P= 8.7e-3) (Fig. 2a, Supple-
mentary Data 1). Note that this analysis was performed without
constraint, and h2SNP,LDMS,common exceeded the overall h2SNP,LDMS
estimate as h2SNP,LDMS,rare was negative. A description of the
statistical test for enrichment is provided in Methods. Supple-
mentary Data 2 provides results on a ﬁner grid of 12 LDMS
components: three MAF bins (1.5e-5 <MAF ≤ 1e-3; 1e-3 <
MAF ≤ 0.01; 0.01 <MAF < 0.5), and four LD score quartiles,
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and further details on the genetic markers used for each of the
components. Common variants contributed essentially all h2SNP,
despite only accounting for 29% of SNPs in the GREML-LDMS
analysis. h2SNP gradually declined across LD score quartiles:
quartiles 1 to 4 contributed 35%, 34%, 19% and 13% of h2SNP,
respectively (Supplementary Data 2).
In summary, the results from our variance component analyses
are consistent with h2 ≈ 60%, including a contribution of 3–4%
from the common SNPs located on the X-chromosome, with
almost 60% of additive genetic variance captured by common
SNPs, and with an enrichment of genetic variance among
common SNPs and lower LD regions (Fig. 2a, Supplementary
Data 1).
Detection of MPB-associated variants. Our GWAS identiﬁed
50,571 autosomal genome-wide signiﬁcant (GWS) SNPs (P < 5e-8
from the BOLT-LMM24 inﬁnitesimal mixed-model association
test, Fig. 3b, Supplementary Data 3), and 8126 X-chromosome
loci (P < 5e-8, Fig. 3c, Supplementary Data 3). We used GCTA-
COJO25 to identify conditionally-independent SNPs using a joint
model, conducting separate analyses for autosomal and X-
chromosome summary statistics. This gave 624 conditionally-
independent loci: 598 autosomal (Supplementary Data 4) and 26
on the X-chromosome (Fig. 3c, d, Supplementary Data 5). The
624 conditionally-independent SNPs explained 0.252 (SE=
0.011) of MPB variance, with 0.223 (SE= 0.010) from the auto-
somal subset and 0.029 (SE= 0.008) from the X-chromosome
subset (Fig. 2b, Supplementary Data 1). Some X-chromosome
SNPs had extremely large effect size, so some variants in high LD
remained after COJO analysis (Supplementary Data 5, Fig. 3d).
We performed selective multiple regression on these SNPs,
eliminating a further two X-chromosome SNPs (Supplementary
Data 6). Ultimately, the net product was 622 loci: 598 autosomal
and 24 on the X-chromosome (Fig. 3, Supplementary Data 4−6).
Downstream analyses. We performed downstream analyses of
the GWAS summary statistics to better understand the genetic
architecture of MPB, and potential functional consequences.
The FUMA SNP2GENE analysis26 provided counts of GWS
SNPs that were represented in various ANNOVAR annotated
categories on the autosomes. The vast majority of SNPS were
located in intergenic and intronic regions, with limited repre-
sentation from 3′-UTR and 5′-UTR, downstream, upstream and
exonic regions (Supplementary Fig. 3a).
We also performed partitioned h2 analysis by cellular
functional annotation, implemented in LDSC27 on autosomes.
The following categories were signiﬁcantly enriched for h2SNP
after multiple-testing correction: conserved regions (P= 7.6e-8),
histone modiﬁcations (H3K27ac, H3K4me1, H3K4me3, H3K9ac;
1.2e-17 < P < 1.7e-7), super enhancers (P= 3.5e-11), DNAse
hypersensitivity sites (DHS; P= 2.8e-8), digital genomic footprint
(DGF; P= 5.7e-7) and transcription factor binding sites (TFBS;
P= 1.61e-6) (Supplementary Fig. 3b, Supplementary Data 12).
We also performed partitioned h2 analysis by cell-type group
(discussed in Supplementary Note 1).
We used FUMA MAGMA gene analysis26 to investigate how
the MPB GWAS results relate to gene function and expression,
ﬁnding 850 autosomal genes that survived Bonferroni correction
(Supplementary Data 13). Subsequent competitive gene-set
analysis demonstrated enrichment for mesenchymal lineages
(skeletal, cartilage, and appendage elements), skin and epidermal
development, and transcriptional elements (Supplementary
Data 14). FUMA GENE2FUNC26 differentially expressed genes
analysis (using GTEx v6) demonstrated enrichment for expres-
sion in skin and vaginal tissue among these genes (Supplementary
Figs. 4, 5).
We uploaded the 624 COJO SNPs to ICSNPathway28, which
prioritises SNPs with functional annotations to identify associated
genes, then groups genes into pathways. This identiﬁed 85
candidate causal pathways with enrichment, including the
ontologies ‘Reproductive’ and ‘Reproductive Pathways’. These
results are discussed in Supplementary Note 1.
Pleiotropy. We used LDSC29 to search for evidence of pleiotropy
in the UKB. Of eight female-limited traits (Supplementary
Data 7), one genetic correlation (rg) with MPB was signiﬁcant
(Bonferroni-corrected threshold P < 0.006): age of menarche
(rg=−0.09, SE= 0.02, P= 2.2e-8) (Table 1). Among male-
limited traits, rg between age of facial hair onset and MPB was
strongest (rg=−0.18, SE= 0.03, P= 1.7e-11), and rg for age at
voice breaking was also signiﬁcant (rg=−0.11, SE= 0.03, P=
1.6e-5). Taken together, the negative rg with ages at facial hair
onset, voice breaking and menarche (in females), suggest genetic
covariance between earlier puberty onset in both sexes and
increased MPB severity (Table 1). Male traits demonstrated
stronger correlation than female traits (Table 1). As a quality
check, all three traits had h2SNP > 0.05 (estimated by LDSC,
Supplementary Data 8).
We used LDHub30 to estimate rg between MPB and over 800
other traits (thresholding for h2SNP < 0.05 and FDR-adjusted P <
0.05), ﬁnding additional statistically-signiﬁcant rg between MPB
and bone mineral density (BMD; both the lumbar spine BMD
studies from 201231 (rg= 0.12, SE= 0.04) and 201532 (rg= 0.15,
SE= 0.04), as well as the UKB heel BMD30 (rg= 0.07, SE=
0.02)), age of menarche 2014 GWAS33 (rg=−0.09, SE= 0.02),
difference in height between childhood and adulthood at age 834
Fig. 2 h2 and variance estimations in the UKB dataset using GCTA-GREML20, 21. Contributions of each component are superimposed upon the
corresponding bar. Error bars denote the standard error. A corresponding table of values is provided in Supplementary Data 1. a Comparisons of h2
estimates. The light grey ‘Repeatability’ bar represents the upper limit of variance explained by genetic factors. Darker grey bars denote pedigree
estimates (h2ped) from pairs of 1st degree relatives (n= 9449 individuals or 5217 pairs), brothers (n= 8010 individuals, or 4428 pairs) and father–son
relationships (n= 1482 individuals, or 789 pairs). Coloured bars represent results from partitioned h2 analyses. ‘bKsK’ bar denotes big K small K h2
estimates ﬁtting three GRMs: (1) standard GRM using autosomal SNPs to calculate relatedness, (2) big K GRM such that rel < 0.05 was set to 0 and (3)
using X-chromosome SNPs to calculate relatedness. ‘MGRM’ shows h2SNP estimates after simultaneously ﬁtting GRMs based on common autosomal and
X-chromosome SNPs, using a dataset only containing classically-unrelated individuals (rel < 0.05). ‘LDMS (MAF)’ shows GREML-LDMS23 results,
compartmentalising by MAF (rare SNPs deﬁned as 1.5e-5 <MAF≤ 0.01, versus common SNPs: MAF > 0.01). Note that the contribution of rare SNPs was
effectively zero (Supplementary Data 2). ‘LDMS (LD)’ illustrates compartmentalisation by low versus high LD (cut-offs determined using genome-wide LD
scores from individual SNPs). b Comparison of variance estimates calculated using COJO-selected GWS SNPs to build the GRM. h2SNP estimates from
GRMs built using (i) genotyped or imputed SNPs and (ii) common or all variants are provided as benchmarks. The number of SNPs used for each analysis
(autosomes+ X-chromosome SNPs) is provided in red text and square brackets
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(rg=−0.16, SE= 0.04), and HOMA-B35 (rg= 0.12, SE= 0.04)
(Table 1, Supplementary Data 8). LDHub reproduced rg that we
had identiﬁed in UKB GWAS, with ages at facial hair onset (rg=
−0.23, SE= 0.04, P= 2.2e-8), voice breaking (rg=−0.12, SE=
0.04, P= 6.0e-4) and menarche (rg=−0.09, SE= 0.02, P= 1.0e-4)
(Supplementary Data 8).
The trait ‘number of children fathered’ had a low h2 from the
LDSC analysis, so we calculated the phenotypic correlation with
age-adjusted MPB. The correlation was weak but signiﬁcant
(Pearson’s r=−0.026, 95%CI: −0.030 to −0.021, n= 203,838,
two-sided P < 2e-16). The regression coefﬁcient of the number of
children fathered against age-adjusted MPB was −0.030 (SE=
0.003, n= 203,838, P < 2e-16), which corresponds to 0.09 fewer
children between men with MPB score of 4 versus 1. This also
equates to −0.033 children per standard deviation of MPB. Given
that the mean number of children fathered is 1.81, and assuming
that relative lifetime reproductive success (number of children
standardised by the mean) is a proxy for ﬁtness, we infer a linear
selection gradient of −0.018 per one standard deviation increase
in MPB36.
Discussion
MPB is a complex trait with interesting genetic characteristics,
and a primary focus of our study was to explore the contribution
of genetic factors to its variance. Our pedigree-based h2 analysis
exploiting ﬁrst-degree relationship pairs in the UKB gave esti-
mates as high as 0.62 (Fig. 2a, Supplementary Data 1). In com-
parison, h2SNP was 0.393 based on common autosomal and X-
chromosome SNPs, and was 0.415 with inclusion of rare
SNPs (1.5e-5 <MAF ≤ 1e-3). The lower father–son correlation
compared to brother–brother pairs (Fig. 2a) may partially reﬂect
X-chromosome contributions, since fathers and sons do not
share X-chromosome loci by descent. Given the considerable
X-chromosome inﬂuence on MPB, we suggest that the
brother–brother estimate may give a better estimate. The
remaining disparity (h2ped difference= 0.208, P= 0.006 from a
two-sided test) may reﬂect sampling variance, non-additive
effects, and common environment shared by brothers. Our big
K small K analyses also showed that the pedigree-based estimate
captured X-chromosome h2SNP as the two-GRM and three-GRM
(with X-chromosome) estimates were both around 0.60 (Sup-
plementary Data 1).
MPB h2 has previously been reported to be 0.81 from a twin
study using self-reported MPB data on a 13-category scale7.
However, this estimate is not directly comparable to our pedigree
estimate of MPB (h2ped= 0.62) due to differences in trait mea-
surement and analysis method. In addition to sampling variation,
the difference in measurement scale and therefore measurement
error is probably the main source of differences between the
estimates. Gianola (1979)37 derived the heritability on the
observed scale (h2o½o) for any linear combination of scores in n
ordinal categories, when the heritability on the scale of liability is
hl2. In the case of observations on MPB, we assume an underlying
continuous scale of liability, n= 4 and observations Y0 takes on
values 1–4 with frequencies πj. This gives Eq. (1):
E h2o½o
h i
¼
h2l
Pn1
j¼1 zj
 2
VðYoÞ
ð1Þ
where zj the height of the normal curve corresponding to
threshold j (4 categories gives 3 thresholds), and V(Yo)=Pn
j¼1 πjw
2
j 
Pn
j¼1 πjwj
 2
, with wj taking on values 1, 2, 3 and
4. Therefore, it follows that:
h2l ¼
h2o½oVðYoÞ
ðz1 þ z2 þ z3Þ2
ð2Þ
Using Eq. (2) to transform our estimates on the observed 1 to
4 scale to the scale of liability increases the estimates by a factor of
approximately 1.18. Hence, assuming a continuous scale of lia-
bility, our transformed estimates of total h2 is 1.18 × 0.62= 0.73.
A recent MPB genetic analysis using the UKB and other
datasets reported a very high h2 of liability to baldness of 1 and
claimed that this was driven by common variants16. The authors
created a binary score from UKBv1 data, deﬁning ‘cases’ (affec-
ted) as individuals with scores 3 and 4 and ‘controls’ (unaffected)
as those with a score of 1. They then transformed the h2 estimate
Table 1 Genetic correlations of MPB
Trait Nindividuals nSNPs h2 (LDSC) rg (SE) P
UKB: Sex-limited traits
Birth weight (ﬁrst child) 149,365 1,012,985 0.103 −0.03 (0.02) 0.14
First birth (age of) 126,958 1,012,966 0.168 0.04 (0.02) 0.05
Last birth (age of) 126,793 1,012,966 0.094 0.02 (0.02) 0.37
Live births (no.) 188,170 1,012,989 0.062 −0.06 (0.02) 0.01
Menarche (age of) 182,937 1,012,994 0.259 −0.09 (0.02) 2.2e-08
Menopause (age of) 107,722 1,012,954 0.133 0.01 (0.02) 0.68
Menstrual cycle (days) 32,552 1,012,843 0.007 0.03 (0.17) 0.84
Stillbirths (no.) 59,258 1,012,843 0.010 0.07 (0.11) 0.53
Prostate cancer 6381 cases; 202,043 controls 1,013,066 0.026 −0.01 (0.03) 0.84
Facial hair (male, relative age) 154,439 1,013,036 0.122 −0.18 (0.03) 1.7e-11
Voice broke (male, relative age) 147,919 1,013,026 0.074 −0.11 (0.03) 1.6e-05
LDHub: Puberty traits
Menarche (age of) (Perry) 182,416 2,441,815 0.204 −0.09 (0.02) 1.0e-04
Diff in height (age 8 vs adult) 18,737 ~2,500,000 0.357 −0.16 (0.04) 1.0e-04
LDHub: Other traits
BMD: Lumbar spine (2015) 53,236 4,268,111 0.128 0.15 (0.04) 3.0e-05
BMD: Heel T-score (UKB) 194,398 10,894,597 0.296 0.07 (0.02) 2.0e-04
HOMA-B 36,466 ~2,500,000 0.087 0.12 (0.04) 1.7e-03
Genetic correlations (rg) between MPB and sex-limited traits from the UK Biobank dataset, as well as statistically-signiﬁcant (P < 0.05, FDR-adjusted) traits from LDHub30. Analyses were performed
using LDSC27 software, and drew upon autosomal data only
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on this 0–1 scale to that of liability, using the proportion of
affected individuals (i.e. those with a score of 3 or 4) in the sample
(i.e. those with a score of 1, 3 or 4) as the population prevalence.
However, excluding individuals with a score of 2 creates an
upward bias, and this ascertainment is unaccounted for. If liabi-
lity to MPB is linear in the scores 1 to 4 (as we have found38),
then the reported estimate of 1 by Pirastu et al.16 is biased by
about one-third, so the actual estimate is consistent with our
results.
Our estimate of the proportion of phenotypic variance cap-
tured by common SNPs is comparable to other h2SNP estimates
for traits such as height39 and childhood intelligence40. Our
GREML-LDMS analysis on the autosomes showed that common
SNPs (MAF > 0.01) essentially explained all h2SNP (fold-enrich-
ment= 3.63, P= 3.6e-177), whereas rare SNPs (1.5e-5 <MAF ≤
0.01) made a very minor contribution. There was also enrichment
in lower LD regions (68%, fold-enrichment= 1.36, P= 8.7e-3)
(Fig. 2a, Supplementary Data 2). However, this analysis did not
capture X-chromosome variants, which is relevant as the MPB-
associated AR region is one of the highest LD regions on the X-
chromosome11. The enrichment for common autosomal variants
in lower LD regions reﬂects a recent BayesS analysis on the
UKBv1 dataset, which found a signature of negative selection
among MPB-associated loci, with an S-parameter estimate of
−0.34641. The dominating contribution of common variants to
MPB was also observed among the 624 conditionally-
independent GWS SNPs (autosomes and X-chromosome). Alto-
gether, these SNPs explained 25% (SE= 1%) of phenotypic var-
iance (Fig. 2b) and 98% (n= 612) were common (MAF > 0.01)
(Supplementary Data 4, Supplementary Data 5). Hence, even
accounting for rare variants, the missing h2 is ≈0.2, which may
suggest environmental or non-additive inﬂation of the estimate.
A BayesS analysis showed that MPB is less polygenic than
classical complex traits such as height, educational attainment
and blood pressure41. Compared to the 2014 height GWAS (n=
253,288)39, our MPB analysis has comparable sample size, and we
detect a similar number of autosomal associated loci (MPB: 598
versus height: 697). However, the top MPB loci tend to have
larger effect size, and explain more variance than the top height
loci (Supplementary Note 2, Supplementary Fig. 6).
We performed the largest GWAS to date, exceeding previous
studies by over 130,000 individuals. We used a mixed-model
GWAS over conventional SNP-by-SNP analyses, allowing us to
include relatives and increase power24. Compared to Hagenaars
et al.8 (who analysed UKBv1), we replicated 219/287 SNPs within
our GWS SNPs (Supplementary Data 9). Pirastu et al.16 found
107 conditionally independent SNPs (103 autosomal SNPs and
four X-chromosome, corresponding to 71 loci) from a UKBv1
case-control design, that they had replicated in separate cohorts at
P < 0.05. Of these, we replicated 71/103 autosomal and all four X-
chromosome SNPs, corresponding to 61/71 loci (Supplementary
Data 10). Prior to 2017, 12 GWS MPB-associated loci had been
identiﬁed, representing 16 independent SNPs18, which were all
replicated (P < 5e-8) in our GWS results (Supplementary
Data 11).
Our variance analyses conﬁrmed that the X-chromosome dis-
proportionally contributes to MPB, relative to its physical length
and number of genes. The X-chromosome makes up around 5%
of the human genome in length, and contains 800–900 of the
20,000–25,000 genes in humans (4.5% at most). Here, 624 con-
ditionally independent GWS SNPs accounted for h2SNP,COJO=
0.252 (SE= 0.011), of which X-chromosome conditionally-
independent GWS SNPs explained 0.029 (SE= 0.008), or 11.6%
(0.029/0.252). In comparison, all common X-chromosome var-
iants explained 8.8% (0.034/0.393) of h2SNP due to common
variation (Supplementary Data 1). This suggests that MPB genetic
architecture on the X-chromosome is less polygenic than on the
autosomes, which is reﬂected by the large-effect X-chromosome
loci (Fig. 3c, Supplementary Data 5). We discuss X-chromosome
loci annotations further in Supplementary Note 1.
Downstream analyses highlighted interesting and plausible
biological pathways that may provide clues for molecular ana-
lyses. These are discussed in detail in Supplementary Note 1.
As MPB has a androgenetic basis, and because there is sexual
dimorphism in androgenetic regulation42, we looked for rela-
tionships with other sex-limited traits. We analysed eight female-
speciﬁc traits with a large sample size (Table 1) in search of proxy
traits that occur when females carry multiple MPB risk alleles.
MPB showed signiﬁcant rg in females with age of menarche (rg=
−0.09, SE= 0.02, P= 2.2e-8), after Bonferroni correction (P <
0.006). In males, we observed signiﬁcant rg with earlier facial hair
appearance (rg=−0.18, SE= 0.03, P= 1.7e-11) and earlier voice
breaking (rg=−0.11, SE= 0.03, P= 1.6e-5). These results indi-
cate a novel association between MPB and earlier onset of puberty
in both sexes. These three traits had h2SNP > 0.07 (estimated by
LDSC), which is reassuring as rg can be hard to interpret when
h2SNP is small (Table 1, Supplementary Data 8). LDHub
strengthened evidence for association between MPB severity and
earlier puberty via earlier age of menarche in the independent
Perry et al.33 dataset (rg=−0.09, SE= 0.02, P= 1.0e-4), and
reduced difference in height between childhood (aged 8) and
adulthood34 (rg=−0.16, SE= 0.04, P= 1.0e-4) (Table 1).
Although the X-chromosome (and X-linked androgen pathway
components) is excluded from LDSC analyses, these results may
be detecting autosomal androgen pathway components (such as
HDAC4, HDAC9, FOXA2, TWIST1 and TWIST2)18. Hence, rg
may be underestimated if the genetic basis of earlier puberty
onset also has X-chromosome components.
The association between early-onset puberty and hair biology
may be reconciled. Androgens regulate hair growth, and simul-
taneously promote facial hair while causing scalp hair regression
in older men43. Although the testes are the major source of
androgens in males from puberty, the adrenal glands are an
important source in both sexes during the earliest detectable stage
of sexual maturation: adrenarche. Adrenarche occurs around the
age of six, precedes pubarche (pubic hair development)44, cor-
relates with puberty onset in both sexes45, and may initiate
puberty via hypothalamic-pituitary-gonadal axis activation46.
Excess adrenal androgens may induce precocious puberty, man-
ifested in congenital adrenal hyperplasia (CAH)46. Both androgen
sources converge upon the androgen signalling pathway, in which
the X-linked AR gene is central.
Adrenarche may have a short evolutionary history as it only
occurs in humans and higher primates46, which is consistent with
the X-linked AR locus having recently been under selection11.
Interestingly, mammalian patterned baldness may also have a
recent evolutionary history as it is conﬁned to a few primate
species47. However, the autosomal LDSC partitioned h2SNP ana-
lysis found enrichment among conserved regions of the genome
(Supplementary Data 12), which may include the Wnt/β-catenin
signalling pathway48.
LDHub also showed statistically-signiﬁcant positive rg between
MPB and bone mineral density (BMD) of lumbar spine (rg=
0.15, SE= 0.04, P= 3.2e-5) and heel (rg= 0.07, SE= 0.02, P=
2.0e-4) (Table 1, Supplementary Data 8). Early puberty correlates
with increased BMD49, suggesting pleiotropy between all three
traits. Our downstream analyses also found enrichment for genes
in bone and mesenchymal pathways and lineages. Both MPB and
BMD are ageing-related traits with predeliction for one sex
(osteoporosis is more prevalent in post-menopausal females).
Similarly to early-onset puberty, androgen production may
underpin both MPB and BMD50. This is supported by multiple
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lines of evidence: androgen-deprivation therapy for prostate
cancer decreases BMD51, whereas hypogonadal men have low
BMD that normalises with testosterone therapy52. Further, CAH
patients with higher adrenal androgens (such as DHEAS), tend to
have higher BMD53, as do women with high testosterone levels
due to polycystic ovarian syndrome (PCOS)54. Interestingly,
strontium ranelate (an osteoporosis therapy) induces alopecia in
some patients55.
We also observed signiﬁcant rg between MPB and HOMA-B
(indicating increased pancreatic β-cell function) (Table 1). There
are epidemiological associations between early-onset MPB and
biomarkers for metabolic dysfunction such as HOMA-IR56
(insulin resistance), but not HOMA-B. Interestingly, genetic loci
contributing to the difference in height between childhood and
adulthood (a marker for early puberty) have been associated with
age of menarche as well as adiposity34 (also a marker of metabolic
dysfunction). The association of MPB with all of these traits adds
to the case for pleiotropy. This is biologically plausible as adipose
tissue can store androgens and metabolise them into oestrogens.
Further, testosterone may increase metabolic dysfunction such as
insulin resistance by decreasing the hormone adiponectin57.
LDHub analyses did not ﬁnd rg between MPB and previously
described epidemiological associations (for prostate cancer, and
coronary artery disease), and the h2SNP estimate for type 2 dia-
betes in this analysis was too low for the estimate to be reliable
(h2SNP= 0.036, SE= 0.003).
Overall, a proposed model to integrate our genetic correla-
tion results is thus: MPB is driven by the androgen pathway,
with components on both autosomes and the X-chromosome.
Androgens are produced by adrenals (in both sexes) and
gonads (particularly testes, in men). Androgen signalling is
associated with puberty onset, which explains rg between MPB
and facial hair appearance, voice breaking, age of menarche and
difference in height between childhood (aged 8) and adulthood
(Table 1). The rg between early-onset puberty and BMD also
manifests clinically, and BMD is subject to androgen modula-
tion. Hence, the rg between MPB and BMD may plausibly be
due to androgen-related pleiotropy. The correlation with
HOMA-B is also supported by epidemiological links with
metabolic disease risk factors, reduced height difference
between childhood and adulthood, and the interrelationship
between androgen metabolism and adipose. Again, these ana-
lyses were only based on autosomal data, which excludes the X-
chromosome contribution to MPB. There may also be gene-
level evidence for pleiotropy among the GWS COJO SNPs
(Supplementary Note 1).
The genetic correlation analyses may also show evidence of
weak negative selection in the contemporary UK population or
alternatively, pleiotropic selection. Our search was motivated by
previous associations of altered androgen regulation with infer-
tility58 and prior identiﬁcation of MPB susceptibility loci within
haplotypes associated with reduced fertility3. In males, we took
the number of children fathered as a male fertility trait, ﬁnding
negative phenotypic correlation with the number of children
fathered (Pearson’s r=−0.026, 95%CI: −0.030 to −0.021). More
concretely, men with MPB score of 4 on average had 0.09 fewer
children than those with MPB score of 1, after adjusting for age.
Furthermore, the signiﬁcant linear selection gradient of −0.018
(P < 2.2e-16) in the contemporary UK population is similar in
magnitude to that reported for other traits in the UKB36. With
regards to MPB and natural selection, it has been suggested that
MPB is a sign of social maturity (independent of age) and
increased appeasement, which may compensate for decreased
attractiveness in reproductive success59. Genetically, the jointly-
independent autosomal SNP rs199441 (Supplementary Data 4) is
within the 17q21.31 H1 haplotype which is under negative
selection among Europeans3, whereas the AR/EDA2R haplotype
(containing the major MPB locus) has recently undergone posi-
tive selection60.
Among female-speciﬁc fertility traits, LDSC identiﬁed nom-
inally signiﬁcant (P < 0.05) rg between increased MPB severity
and fewer number of live births (rg=−0.06, SE= 0.02) and
increased age of ﬁrst birth (rg= 0.04, SE= 0.02) (Table 1), sug-
gesting shared genetic risk. These directions of effect point
towards lower female fertility, and negative selection. There is
also S-parameter evidence for negative selection on age of
menarche (which is permissive for reproduction), and on age at
ﬁrst live birth41. These two traits show opposing directions of
effect between (a) lifetime reproductive success (LRS) (age
of menarche: positive; age at ﬁrst live birth: negative36) and (b) rg
with MPB (age of menarche: negative; age at ﬁrst live birth:
positive), which is consistent with MPB being negatively corre-
lated with LRS and fertility. The enrichment for low LD variants
in our h2 analyses support a case for weak negative selection in
MPB, as do downstream analyses indicating relationships
between MPB COJO SNPs and fertility-related genes (Supple-
mentary Note 1).
Given our results linking MPB to BMD, MPB may be a useful
model trait for other late-onset diseases that are biased towards
one sex (such as osteoporosis61 and sarcopenia62). Biologically,
such traits share a basis in sex-hormone regulation, so it will be
interesting to investigate pleiotropy and similarities in genetic
architecture.
In summary, we show that MPB is a highly polygenic,
partially X-linked and heritable trait in the UKB, and that
almost 60% of the additive genetic variation is captured by
common SNPs. We ﬁnd plausible genetic evidence to suggest
androgen-related pleiotropy with early-onset puberty, BMD
and metabolic traits, and ﬁnd that MPB is an interesting
genetic trait in its own right. Overall, our results for MPB are
consistent with the emerging genetic and evolutionary prop-
erties of many complex traits in human populations63. More
broadly, the availability of extremely large datasets of genome-
wide genotypes and phenotypes in human populations allows
insights into the genetic architecture of complex traits, and the
pleiotropic mechanisms that may underlie proxy traits or
medical comorbidities.
Methods
Phenotype data. The UKB dataset contains MPB self-report data from 224,897
males. Individuals were asked to match their balding pattern to four images
(Supplementary Fig. 1). MPB scores 1 to 4 respectively correspond to no balding,
vertex balding, crown balding and a combination of vertex and crown balding. Of
the 224,897 males, we selected 205,327 who self-identiﬁed as British, Irish or other
White ancestry, were genetically-European from the leading principal components
(PCs) of the SNP genotype data, had genotyping data available from the UKB
Phase 2 (UKBv2) genotyping and imputation release, and were conﬁrmed to be
genetically-male. Our phenotypes for analysis are residuals from regressing the
MPB scores on age, assessment centre, ethnicity and 40 principal components
calculated using the UKB European population (Fig. 1d). Throughout the manu-
script, the residuals are referred to as ‘adjusted MPB scores’ (Fig. 1d).
Genotype data. Supplementary Fig. 2 provides an overview of the data quality
control (QC) workﬂow used across analyses, performed using PLINK 1.964,65. We
used autosomal genotype data imputed to the Haplotype Reference Consortium
(HRC) reference panel provided by the UKB66. The UKB-provided genotype
probabilities were used to hard-call the genotypes for variants with an imputation
info score > 0.3. We used the hard-call-threshold 0.1, setting the genotypes with
P ≤ 0.9 as missing. For the autosomal GWAS analysis, we retained the hard-called
variants with minor allele frequency (MAF) > 0.0001, missing genotype rate < 0.05
and Hardy–Weinberg equilibrium (HWE) P > 1e-6 as computed in the sample of
unrelated Europeans, such that 18,065,087 autosomal SNPs remained. For the
heritability analyses, 1,123,347 HapMap3 variants passed our quality control ﬁlters
(MAF > 0.01, missing genotype rate < 0.05 and HWE P > 1e-6) in the set of 456,419
male and female Europeans; these were used to estimate a GRM for 205,327 males.
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Imputed X-chromosome genotypes were not provided in the full UKB
release from 2017. We imputed the non-pseudo-autosomal and pseudo-
autosomal region (PAR1) to the 1000 Genomes phase 3 mixed population
reference panel using IMPUTE2. The imputation pipeline followed is available
at https://github.com/CNSGenomics/impute-pipe. The genotyped SNPs used
for imputation were those used for X-chromosome UKB phasing input, passing
additional QC ﬁlters (the common set of SNPs with missing genotype rate <
0.05 and MAF > 0.0001 in both males and females and HWE P > 1e-6 in
females, as males are haploid) in the set of unrelated Europeans, excluding those
participants that were (1) heterozygosity or missingness outliers, (2) had
inconsistent reported and biological sex, (3) were aneuploid, (4) if they had
been excluded from kinship inference by the UKB or (5) if they had withdrawn
their consent. After the imputation, we retained markers with imputation info
score > 0.3 and again estimated QC metrics in the set of unrelated Europeans.
For the non-pseudo-autosomal region, we kept the markers with MAF > 0.0001
in both males and females, and those with HWE P > 1e-6. The same thresholds
applied for PAR1, without stratifying by sex. This left 1,064,602 X-chromosome
SNPs (1,024,430 non-PAR and 40,172 PAR1 SNPs) for use in GWAS. For the
heritability analyses, we used a subset of 262,588 X-chromosome markers with
MAF > 0.01, estimated in the 205,327 males.
In addition, we created an LD pruned (LD r2 > 0.9, window size= 1000 SNPs,
step size= 100) set of common autosomal HapMap3 variants (MAF > 0.01) to
calibrate the GWAS analysis, as required by the BOLT-LMM software24.
Ethics. The UK Biobank study protocol has ethics approval from the North West
Multi-centre Research Ethics Committee (covering the UK), the Research Tissue
Bank, and all participants provided written informed consent (https://www.
ukbiobank.ac.uk/the-ethics-and-governance-council/).
Female data. We used data from females in our genetic correlation analyses for the
following female-limited traits: birth weight of ﬁrst child, age at ﬁrst child, age at
last child, age of menarche, age of menopause, length of menstrual cycle (only
including women with regular periods), number of live births and number of
stillbirths (Supplementary Data 7). For each of the phenotypes, we selected for
analysis genetically-female individuals who were genetically-European from the
leading principal components (PCs) of the SNP genotype data, and whom had
genotyping data available from the UKBv2 genotyping and imputation release.
Table 1 gives the number of female participants in each genetic correlation analysis.
Narrow-sense heritability (h2) estimation. To benchmark all estimates of var-
iance explained, we estimated repeatability: the correlation between repeated
observations on the same individuals. Repeatability can be due to genetic and
permanent environmental effects and is an upper limit of a trait’s broad sense
heritability (H2)67. We estimated repeatability by calculating the correlation
between MPB measurements taken from 2006–2010, to those taken from the same
individuals during 2012–2013 (n= 9603).
UKB-provided kinship estimates66 were used to infer ﬁrst-degree relationships.
Among MPB males, we identiﬁed a set of 9449 individuals (5217 pairs) with a ﬁrst-
degree relative. Of these, a subset of 1482 males were in a father–son relationship
(789 pairs), and 8010 males were in a brother–brother relationship (4428 pairs).
For each of these three sets of individuals, we estimated variance components using
REML to simulate a true pedigree analysis, with ﬁrst-degree relationships set to 0.5
and all others set to 0, using GCTA software20,21.
We performed a number of variance component analyses to estimate and
partition phenotypic variation associated with common SNPs in both closely-
related and conventionally-unrelated individuals. These analyses help dissect the
contribution from common versus rare variants and shared environmental effects,
since rare variants are not well tagged by common SNPs, and close relatives may
share common environmental effects20. Given constraints on computational
resources, we maximised the number of individuals with relatives (estimated
relatedness from SNP data > 0.05) so as to estimate both variance components with
good precision. Speciﬁcally, the maximum dataset (n= 87,957) used in our h2
analyses included 47,957 individuals with relatives in the data, and a random
sample of 40,000 singletons (individuals with no relatives) (Supplementary Fig. 2).
We estimated variances associated with both close and distant relatives
simultaneously using a ‘big K small K’ analysis22 of the full set of 87,957 males. The
analysis used two GRMs (built using GCTA20,21): the big K GRM in which
relatedness coefﬁcients < 0.05 based on autosomes were set to 0, and the
conventional GRM constructed from common autosomal (1,123,347 SNPs) and X-
chromosome markers (262,588 SNPs). This sample of 87,957 contains a maximum
set of 75,654 unrelated males, using a rel < 0.05 threshold on a genetic relationship
matrix (GRM) calculated using 1,123,347 common autosomal SNPs. We used these
individuals in REML analyses to estimate the h2SNP attributable to common
autosomal SNPs alone, common X-chromosome SNPs alone, and both common
autosomal and X-chromosome SNPs.
To partition genetic variation according to allele frequency and linkage
disequilibrium (LD) score, we performed a GREML-LDMS analysis23 (with the no
constraint setting) on all autosomal markers (n= 25,246,483) from the unrelated
subset (n= 75,654). We divided SNPs into three bins based on MAF (1.5e-5 <
MAF ≤ 1e-3; 1e-3 <MAF ≤ 0.01; 0.01 <MAF < 0.5) and four quartiles based on LD
score in a genome-wide manner, giving a total of 12 LDMS components
(Supplementary Data 2). Throughout the manuscript however, we compared
components for low versus high LD (based on median LD score), and rare (1.5e-5
<MAF ≤ 0.01) versus common (0.01 <MAF < 0.5) variants. We used the individual
SNP LD score as this has been shown to be superior68, deﬁned as the sum of the LD
r2 scores between all SNPs within a 20Mb region centred on that SNP.
We tested for h2SNP enrichment in the GREML-LDMS components for low
versus high LD and rare versus common variants. We deﬁne h2C and MC as the
heritability estimate and the number of SNPs for category C respectively. Then the
fold-enrichment can be calculated by the ratio of per SNP h2, as in Eq. (3):
h2C ´M=ðMC ´ h2Þ ð3Þ
where h2 is the total heritability and M is the total number of SNPs included in the
analysis.
To test the signiﬁcance of this enrichment, we can construct Eq. (4).
Z ¼ h
2
C
MC
 h
2  h2C
M MC
ð4Þ
The standard error can be estimated using the covariance matrix for LDMS
component estimates.
Identiﬁcation of MPB-associated variants. An additive mixed linear model
association analysis (implemented in BOLT-LMMv2.324) was performed using the
autosomal and X-chromosome genotype data, with adjusted MPB scores as the
dependent quantitative trait. BOLT-LMM accounts for genetic relationships
between individuals, so we used the full set of MPB males (n= 205,327). We used
the LD-pruned autosomal SNPs (described in Genotype data section) to calibrate
the analysis via the –modelSnps command. We selected genome-wide signiﬁcant
(GWS) SNPs using a signiﬁcance threshold P < 5e-8, under the inﬁnitesimal mixed
model. Note that males are haploid for the X-chromosome. Hence, although the
actual number of alleles is 0/1, BOLT-LMM encodes males as 0/2. Thus, the per-
allele effect size is half the effect size reported in the summary statistics output for
X-chromosome SNPs.
Classical LD-clumping to identify GWS loci is based on a user-speciﬁed LD r2
threshold. If this threshold is small then truly independent loci may be excluded;
however, use of the standard threshold of r2= 0.2 may retain SNPs that are
associated by LD because some effect sizes are so large. Instead, we used GCTA-
COJO25 to identify a smaller set of jointly-signiﬁcant MPB-associated SNPs.
Although COJO is built for autosomal (diploid) analysis, analysis of the X-
chromosome separately from autosomes overcomes this issue.
We opted for the summary statistics option as the –cojo-actual-geno method
(that uses the same individual-level genotype data as the for the GWAS) is not built
to analyse the X-chromosome.
We quantiﬁed the variance explained by the COJO-selected independent GWS
SNPs, by creating a GRM from these SNPs on the set of 75,654 unrelated males and
estimating the variance explained using REML. Since the discovery and test sets are
not independent, we expect a (slight) upward bias in this estimate, even if our
criteria for inclusion of SNPs are stringent.
Downstream analyses. We used three tools to investigate the top GWS SNPs:
FUMA GWAS (Functional Mapping and Annotation of Genome Wide Association
Studies)26, partitioned h2SNP analyses implemented in LDSC27, and ICSNPathway28.
We input the GWAS summary statistics into FUMA26, using p-values from the
non-inﬁnitesimal mixed model. We include here results from the SNP2GENE tool
(MAGMA v1.6 gene and competitive gene-set analysis, which uses the 1000
Genomes Phase 3 reference; MAGMA Tissue Expression Analysis, which uses
GTEx v6 data; and ANNOVAR functional consequences of SNPs on genes), as well
as from the GENE2FUNC tool (examining differentially expressed genes by GTEx
v6 tissue types). Note that these analyses only consider autosomal data.
We used LDSC to partition heritability on the autosomes by functional
annotation, and for cell-group-type analysis27. We used 1000 Genomes Phase 3
functional annotation categories, which included coding, 3′-UTR, 5′-UTR,
promoters, enhancers, introns, histone modiﬁcations, DNAse I hypersensitivity
sites (DHS), protein binding sites (CTCF and transcription factors) and conserved
regions (in mammals), as described by Finucane et al.27. Ten cell-type-groups were
included in the analysis, including adrenal/pancreas, cardiovascular, central
nervous system (CNS), connective tissue and bone, gastrointestinal,
haematopoietic, kidney, liver, ‘other’ (which includes adipose nuclei, breast tissue,
ovary, penis foreskin and placenta) and skeletal muscle.
We uploaded COJO SNPs to ICSNPathway28 to look for functional associations
of the GWS SNPs. For this analysis, we used default settings (European American
HapMap population, r2 > 0.8, LD neighbourhood distance= 200 kb, FDR < 0.05
cut-off for pathway-based analysis), with the exception of the gene window
(looking for genes within 100 kb of the uploaded SNPs).
Relationships between MPB and other traits. As the androgenetic pathway is a
major contributor to MPB15,18, and androgen signalling is associated with male
fertility58, we investigated whether MPB is related to reproductive success and
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hormone-associated traits in both males and females. For genetic correlation
analysis, we selected eight female traits, as described in Female data above, and for
males, we selected relative age of ﬁrst facial hair (n= 152,467 had both MPB and
facial hair data available), and relative age of voice breaking (n= 146,130 had both
MPB and voice breaking data available). Both traits are scored as 1: ‘younger than
average’, 2: ‘average’, and 3: ‘older than average’. We also included prostate cancer
in our genetic correlation analyses (cases= 6381, controls= 202,043). Details of
coding, exclusion criteria and UK Biobank Field Codes are provided in Supple-
mentary Data 7.
We used the UK Biobank data and HapMap3 SNPs to generate GWAS
summary statistics for each of the eight female traits, and three male traits (facial
hair, voice breaking and prostate cancer) (GWAS details in Table 1). We used
LDSC29,69 to calculate genetic correlations between these traits and MPB, based on
autosomal data only. LD scores were calculated using the European UK Biobank
population. LDSC standard errors are calculated using a block jackknife approach,
and p-values are calculated by jackkniﬁng the regression numerator and applying a
Z-test27.
We input the MPB summary statistics into LDHub30 to look for genetic
correlations with many other traits. At the time of writing, LDHub had 832 GWAS
available to test against. We only present results with h2observed > 0.05 to ensure that
the associations were robust.
We also determined phenotypic correlations between the male traits, as well as
between age-adjusted MPB with the trait ‘number of children fathered’ (n=
203,838). Individuals who reported fathering > 20 children were excluded from the
analysis.
URLs. Data was obtained from the UK Biobank at http://www.ukbiobank.ac.uk/.
All analyses were performed using publicly available software: PLINK 1.9 at https://
www.cog-genomics.org/plink2; GCTA at http://cnsgenomics.com/software/gcta/;
BOLT-LMM at https://data.broadinstitute.org/alkesgroup/BOLT-LMM/; FUMA at
http://fuma.ctglab.nl/; LDSC at https://github.com/bulik/ldsc; LDHub at http://ldsc.
broadinstitute.org/; and ICSNPathway at http://icsnpathway.psych.ac.cn.
Data availability
The data used to generate the ﬁndings of this study are available from the UK
Biobank, under project number 12505 (http://www.ukbiobank.ac.uk/). The
individual-level data is available upon application to the UK Biobank. The source
data underlying Fig. 2 are provided in Supplementary Data 1. Summary statistics
on the SNPs with P < 5e-8 in Fig. 3b and Fig. 3c are provided in Supplementary
Data 3. The full GWAS summary statistics are available at http://cnsgenomics.com/
data.html. A Reporting Summary for this Article is available as a Supplementary
Information ﬁle.
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